AUTM Newsbrief
Nov. 11, 2010

Collaborating with universities helps businesses
eGov monitor
While technology transfer has often been the focus for policy makers and researchers in terms of understanding business — academia collaboration, this new survey shows that these partnerships enable businesses to improve wide ranging activities including service development, human resource management, and even marketing. Collaborations are primarily based on problem solving, people- or community-based interactions rather than technology transfer. The survey is part of a research project examining business-university knowledge exchange partnerships, their effectiveness and regional impact. As well as the business survey, which generated over 2,500 responses, the research included an academic survey with over 22,000 responses and several case studies. The survey of academics shows that the knowledge exchange activities had significant positive impacts on research and teaching.More

Roche Supreme Court case to test Bayh-Dole Act
The Stanford Daily
The fight between Stanford University and biotechnology firm Roche Holdings AG is heating up as the U.S. Supreme Court is set to hear the patent dispute. The lawsuit could upset current interpretations of the Bayh-Dole Act of 1980, which defines the ownership of patents that arise from research at federally funded institutions. The case questions whether an inventor employed by a contractor that decides to retain ownership of a patent can negate that contractor's ownership under Bayh-Dole by assigning his rights to the invention to another party. It started in 2002 when the University sued Roche for royalties on HIV screening kits sold by the company that used technology developed by School of Medicine professor Mark Holodniy.More

Kansas State University research team receives patent to
control destructive parasite

Kansas State University via
The invention, "Compositions and Methods for Controlling Plant Parasitic Nematodes," was developed by four Kansas State University researchers: Harold Trick, professor of plant pathology; Timothy Todd, an instructor of plant pathology; Michael Herman, associate professor of biology; and Judith Roe, former assistant professor of biology. The researchers focused their work on the soybean cyst nematode, a destructive parasite that attacks the roots of soybean plants. Farmers across the country lose nearly $860 million every year because of the nematode. The research foundation is working with the National Institute for Strategic Technology Acquisition and Commercialization, to license the patent, said Marcia Molina, foundation vice president. More

Biotech pioneer launches Santa Rosa incubator
The Press Democrat
Healdsburg biotech pioneer Howard Leonhardt invented medical technology that made millions of dollars for Medtronic Inc., the world's largest medical device maker. Now he's launching a Santa Rosa tech incubator designed to give new medical technologies a chance to take off. He's partnering with the University of Northern California in Santa Rosa, a small private institute that focuses on biomedical engineering. "In this recession, it's hard to find markets that are growing," said Leonhardt, who also founded Bioheart, a Florida biotech company.More

Global car giants testing Auckland University technology
The National Business Review
The University of Auckland has developed what is understood to be the world's first wireless technology that allows parked or moving electric cars to charge automatically. The breakthrough technology, which is owned by U.K.-based HaloIPT, was developed by the university's Power Electronics Group. HaloIPT was founded by Auckland UniServices, which manages the University's intellectual property and is responsible for all research-based consultancy partnerships, and Australian structural engineering company Ove Arup & Partners.More

Abbott challenges $1.67 billion patent loss to Johnson & Johnson
over Humira

Abbott Laboratories urged a U.S. appeals court to throw out a $1.67 billion patent-infringement verdict, the largest in U.S. history, set after a jury found the company used Johnson & Johnson's technology to develop the arthritis drug Humira. Abbott is focusing its appeal on the validity of the patent, co-issued to New York University and Johnson & Johnson's Centocor unit. Humira, Abbott's biggest drug, includes human antibodies that aren't covered by the patent, a lawyer for the Abbott Park, Illinois-based company said. More

Hydrogen ICE for HD vehicles under development in Japan
NGV Global
Researchers from Tokyo City University and the National Traffic Safety and Environment Lab in Japan are developing a multi-cylinder direct-injection spark-ignition hydrogen internal combustion engine for application in heavy-duty vehicles. The project aims to deliver a hydrogen ICE system combining high power output and low NOx generation. The research team published a paper on their efforts in conjunction with the recent SAE Powertrains Fuels & Lubricants meeting, according to a Green Car Congress report. The university said it will seek to commercialize the vehicle.More

University at Buffalo spin-off wins FDA orphan designation for
drug made from tarantula venom

University at Buffalo
As Rose Pharmaceuticals marks its first anniversary, the stockbroker and University at Buffalo researchers who founded the company are celebrating a year of accomplishments. The startup's biophysicists have secured state and foundation funding to advance their product — a peptide found in tarantula venom — toward clinical trials as a therapy for muscular dystrophy. The U.S. Food and Drug Administration has designated the firm's peptide, called GsMTx4, as an orphan drug for Duchenne muscular dystrophy. The status qualifies Rose for tax credits and other incentives that could help the firm move the product to the market more quickly.More

University of Birmingham and Abingdon Health launch medical diagnostics joint venture
Birmingham Science City
The University of Birmingham and medical diagnostics specialists, Abingdon Health Ltd, announce the launch of Bioscience Ventures Limited ("Bioscience Ventures"), a new joint venture aimed at developing and marketing new diagnostics products for the health care and other industries. Biosciences Ventures will focus on developing new diagnostic tools for conditions where there are currently unmet needs in the market such as various forms of cancer, genetic related diseases and platform technologies with applications in many areas of medicine including infectious disease testing, drug testing and veterinary applications utilizing intellectual property developed at the University of Birmingham. Operating from the University's campus in the United Kingdom and through its established trading subsidiary company, Alta Bioscience Ltd, Bioscience Ventures will also provide a variety of services such as analysis and synthesis of DNA, protein and other biochemicals to clients both on and off campus in the pharmaceutical and food industries.More